{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:42:57Z","timestamp":1773409377326,"version":"3.50.1"},"reference-count":50,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":731,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Surg. Oncol."],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1002\/jso.23422","type":"journal-article","created":{"date-parts":[[2013,8,31]],"date-time":"2013-08-31T10:59:04Z","timestamp":1377946744000},"page":"457-464","source":"Crossref","is-referenced-by-count":30,"title":["Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy"],"prefix":"10.1002","volume":"108","author":[{"given":"Ming-Yii","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology; Kaohsiung Medical University Hospital; Kaohsiung Taiwan"},{"name":"Department of Radiation Oncology; Faculty of Medicine, College of Medicine, Kaohsiung Medical University; Kaohsiung Taiwan"},{"name":"Cancer Center; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiang-Lin","family":"Tsai","sequence":"additional","affiliation":[{"name":"Cancer Center; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Taiwan"},{"name":"Division of General Surgery Medicine, Department of Surgery; Kaohsiung Medical University Hospital; Kaohsiung Taiwan"},{"name":"Program of Bachelor of Health Beauty; School of Medical and Health Sciences, Fooyin University; Kaohsiung Taiwan"},{"name":"Graduate Institute of Medicine; College of Medicine, Kaohsiung Medical University; Kaohsiung Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hung","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Wen","family":"Huang","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medicine; College of Medicine, Kaohsiung Medical University; Kaohsiung Taiwan"},{"name":"Department of Surgery, Kaohsiung Municipal Hsiao-Kang Hospital; Kaohsiung Medical University; Kaohsiung Taiwan"},{"name":"Division of Gastrointestinal and General Surgery, Department of Surgery; Kaohsiung Medical University Hospital; Kaohsiung Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Jen","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Gastrointestinal and General Surgery, Department of Surgery; Kaohsiung Medical University Hospital; Kaohsiung Taiwan"},{"name":"Graduate Institute of Clinical Medicine; College of Medicine, Kaohsiung Medical University; Kaohsiung Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Ming","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Kaohsiung Medical University Hospital; Kaohsiung Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee-Yin","family":"Chai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Taiwan"},{"name":"Department of Pathology; Faculty of Medicine, College of Medicine, Kaohsiung Medical University; Kaohsiung Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaw-Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Cancer Center; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Taiwan"},{"name":"Graduate Institute of Medicine; College of Medicine, Kaohsiung Medical University; Kaohsiung Taiwan"},{"name":"Graduate Institute of Clinical Medicine; College of Medicine, Kaohsiung Medical University; Kaohsiung Taiwan"},{"name":"Department of Surgery; Faculty of Medicine, College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan"},{"name":"Department of Genomic Medicine; College of Medicine, Kaohsiung Medical University; Kaohsiung Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,8,31]]},"reference":[{"key":"10.1002\/jso.23422-BIB0001|jso23422-cit-0001","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/sj.bjc.6605962","article-title":"Socioeconomic position and participation in colorectal cancer screening","volume":"103","author":"Frederiksen","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1002\/jso.23422-BIB0002|jso23422-cit-0002","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1002\/jso.23422-BIB0003|jso23422-cit-0003","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(05)17706-X","article-title":"Colorectal cancer","volume":"365","author":"Weitz","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/jso.23422-BIB0004|jso23422-cit-0004","unstructured":""},{"key":"10.1002\/jso.23422-BIB0005|jso23422-cit-0005","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1002\/1097-0142(19930615)71:12+<4225::AID-CNCR2820711811>3.0.CO;2-C","article-title":"Standard postoperative monitoring of patients after primary resection of colon and rectum cancer","volume":"71","author":"Steele","year":"1993","journal-title":"Cancer"},{"key":"10.1002\/jso.23422-BIB0006|jso23422-cit-0006","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF02054122","article-title":"Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up","volume":"38","author":"Ohlsson","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"10.1002\/jso.23422-BIB0007|jso23422-cit-0007","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1002\/jso.23422-BIB0008|jso23422-cit-0008","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/jcp.22801","article-title":"PML as a potential predictive factor of oxaliplatin\/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients","volume":"227","author":"Vincenzi","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1002\/jso.23422-BIB0009|jso23422-cit-0009","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/annonc\/mdp336","article-title":"EGF61A\u2009>\u2009G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer","volume":"21","author":"Spindler","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1002\/jso.23422-BIB0010|jso23422-cit-0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1568009033333727","article-title":"Mechanisms controlling sensitivity to platinum complexes: Role of p53 and DNA mismatch repair","volume":"3","author":"Manic","year":"2003","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1002\/jso.23422-BIB0011|jso23422-cit-0011","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev.bi.65.070196.000355","article-title":"DNA excision repair","volume":"65","author":"Sancar","year":"1996","journal-title":"Annu Rev Biochem"},{"key":"10.1002\/jso.23422-BIB0012|jso23422-cit-0012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0300-9084(99)80034-0","article-title":"Nucleotide excision repair: From E. coli to man","volume":"81","author":"Petit","year":"1999","journal-title":"Biochimie"},{"key":"10.1002\/jso.23422-BIB0013|jso23422-cit-0013","first-page":"959","article-title":"Excision repair cross complementing-group 1: Gene expression and platinum resistance","volume":"14","author":"Altaha","year":"2004","journal-title":"Int J Mol Med"},{"key":"10.1002\/jso.23422-BIB0014|jso23422-cit-0014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-4598-4-18","article-title":"ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines","volume":"4","author":"Weaver","year":"2005","journal-title":"Mol cancer"},{"key":"10.1002\/jso.23422-BIB0015|jso23422-cit-0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/FPC.0b013e3283415124","article-title":"Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy","volume":"21","author":"Huang","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1002\/jso.23422-BIB0016|jso23422-cit-0016","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","article-title":"Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy","volume":"24","author":"Reed","year":"1998","journal-title":"Cancer Treat Rev"},{"key":"10.1002\/jso.23422-BIB0017|jso23422-cit-0017","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0006-2952(00)00441-X","article-title":"Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: Role of ERCC1-XPF","volume":"60","author":"Ferry","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/jso.23422-BIB0018|jso23422-cit-0018","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/jnci\/84.19.1512","article-title":"ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients","volume":"84","author":"Dabholkar","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/jso.23422-BIB0019|jso23422-cit-0019","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbrc.2004.12.008","article-title":"Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin","volume":"327","author":"Chang","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/jso.23422-BIB0020|jso23422-cit-0020","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1158\/1078-0432.CCR-05-1083","article-title":"ERCC1 and clinical resistance to platinum-based therapy","volume":"11","author":"Reed","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jso.23422-BIB0021|jso23422-cit-0021","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(10)60353-4","article-title":"Colorectal cancer","volume":"375","author":"Cunningham","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/jso.23422-BIB0022|jso23422-cit-0022","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0093-7754(01)90247-7","article-title":"Should Dukes' B patients receive adjuvant therapy? A statistical perspective","volume":"28","author":"Buyse","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1002\/jso.23422-BIB0023|jso23422-cit-0023","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2407-8-50","article-title":"ERCC2 2251A\u2009>\u2009C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: A preliminary study","volume":"8","author":"Huang","year":"2008","journal-title":"BMC cancer"},{"key":"10.1002\/jso.23422-BIB0024|jso23422-cit-0024","first-page":"109","article-title":"Treatment and prognosis in colorectal cancer patients with bone metastasis","volume":"9","author":"Nozue","year":"2002","journal-title":"Oncol Rep"},{"key":"10.1002\/jso.23422-BIB0025|jso23422-cit-0025","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0039-6109(02)00050-6","article-title":"The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer","volume":"82","author":"Longo","year":"2002","journal-title":"Surg Clin North Am"},{"key":"10.1002\/jso.23422-BIB0026|jso23422-cit-0026","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12094-011-0676-z","article-title":"Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients","volume":"13","author":"Watanabe","year":"2011","journal-title":"Clin Transl Oncol"},{"key":"10.1002\/jso.23422-BIB0027|jso23422-cit-0027","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1200\/JCO.2009.21.7943","article-title":"Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: Results from North American Gastrointestinal Intergroup Trial N9741","volume":"28","author":"McLeod","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1002\/jso.23422-BIB0028|jso23422-cit-0028","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/bjc.2012.595","article-title":"Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer","volume":"108","author":"Lu","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1002\/jso.23422-BIB0029|jso23422-cit-0029","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1200\/JCO.2005.17.749","article-title":"Systemic therapy for metastatic colorectal cancer: Current options, current evidence","volume":"23","author":"Kelly","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1002\/jso.23422-BIB0030|jso23422-cit-0030","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1023\/A:1008213732429","article-title":"Oxaliplatin: A review of preclinical and clinical studies","volume":"9","author":"Raymond","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1002\/jso.23422-BIB0031|jso23422-cit-0031","first-page":"4","article-title":"Oxaliplatin: Mechanism of action and antineoplastic activity","volume":"25","author":"Raymond","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1002\/jso.23422-BIB0032|jso23422-cit-0032","first-page":"1205","article-title":"Clinical pharmacokinetics of oxaliplatin: A critical review","volume":"6","author":"Graham","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jso.23422-BIB0033|jso23422-cit-0033","first-page":"227","article-title":"Cellular and molecular pharmacology of oxaliplatin","volume":"1","author":"Raymond","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/jso.23422-BIB0034|jso23422-cit-0034","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/JTO.0b013e31815ba2a1","article-title":"Platinum resistance related to a functional NER pathway","volume":"2","author":"Rosell","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1002\/jso.23422-BIB0035|jso23422-cit-0035","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ctrv.2007.07.001","article-title":"Current status of excision repair cross complementing-group 1 (ERCC1) in cancer","volume":"33","author":"Gossage","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1002\/jso.23422-BIB0036|jso23422-cit-0036","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/COC.0b013e31817be58e","article-title":"Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU\/oxaliplatin chemotherapy in advanced colorectal cancer","volume":"32","author":"Kim","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1002\/jso.23422-BIB0037|jso23422-cit-0037","first-page":"362","article-title":"Relationship between ERCC1 expression and cisplatin intervention in human lung adenocarcinoma cell lines","volume":"10","author":"Xia","year":"2007","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1002\/jso.23422-BIB0038|jso23422-cit-0038","first-page":"2531","article-title":"Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells","volume":"30","author":"Seetharam","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1002\/jso.23422-BIB0039|jso23422-cit-0039","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ijc.11547","article-title":"Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers","volume":"108","author":"Schuster","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1002\/jso.23422-BIB0040|jso23422-cit-0040","first-page":"401","article-title":"Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma","volume":"143","author":"Weidner","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1002\/jso.23422-BIB0041|jso23422-cit-0041","first-page":"411","article-title":"Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel","volume":"28","author":"Yeh","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1002\/jso.23422-BIB0042|jso23422-cit-0042","first-page":"8654","article-title":"A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer","volume":"61","author":"Park","year":"2001","journal-title":"Cancer Res"},{"key":"10.1002\/jso.23422-BIB0043|jso23422-cit-0043","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1349-7006.2009.01186.x","article-title":"Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma","volume":"100","author":"Lai","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1002\/jso.23422-BIB0044|jso23422-cit-0044","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.biochi.2003.11.003","article-title":"The base excision repair: Mechanisms and its relevance for cancer susceptibility","volume":"85","author":"Fortini","year":"2003","journal-title":"Biochimie"},{"key":"10.1002\/jso.23422-BIB0045|jso23422-cit-0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0975-1483.76414","article-title":"Biodegradable chitosan-based ambroxol hydrochloride microspheres: Effect of cross-linking agents","volume":"3","author":"Gangurde","year":"2011","journal-title":"J Young Pharm"},{"key":"10.1002\/jso.23422-BIB0046|jso23422-cit-0046","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s12253-012-9536-6","article-title":"Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer","volume":"18","author":"Lv","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"10.1002\/jso.23422-BIB0047|jso23422-cit-0047","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1158\/1078-0432.CCR-11-2863","article-title":"Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer","volume":"18","author":"Wang","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jso.23422-BIB0048|jso23422-cit-0048","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1158\/1078-0432.CCR-10-1604","article-title":"High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma","volume":"17","author":"Ang","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jso.23422-BIB0049|jso23422-cit-0049","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1590\/S1807-59322009000400004","article-title":"Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients-Is it important","volume":"64","author":"Filiz","year":"2009","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1002\/jso.23422-BIB0050|jso23422-cit-0050","first-page":"9","article-title":"Sublingual immunotherapy and oral mucosal langerhans cells","volume":"3","author":"Blazquez","year":"2011","journal-title":"Immunotherapy"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.23422","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jso.23422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T22:34:22Z","timestamp":1563834862000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/jso.23422"}},"subtitle":["ERCC1 in CRC Received FOLFOX-4 Treatment"],"short-title":[],"issued":{"date-parts":[[2013,8,31]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1002\/jso.23422","relation":{},"ISSN":["0022-4790"],"issn-type":[{"value":"0022-4790","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8,31]]}}}